研究药物用于治疗硬化皮肤病:有什么新鲜事?
Jelena Colic1, Corrado Campochiaro2,3, Michael Hughes4
1Department of Rheumatology, Institute of Rheumatology, Belgrade, Serbia.
Expert opinion on investigational drugs
|August 1, 2023
概括
系统性硬化症 (SSc) 是一种致命的纤维性疾病. 本综述审查了早期试验中的新向疗法,以改善治疗结果并防止不可逆转的损害.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 纤维性疾病 纤维性疾病
背景情况:
- 系统性硬化症 (SSc) 是一种罕见的慢性自身免疫纤维性疾病,死亡率高.
- 它的特点是渐进的纤维化,影响皮肤和内部器官.
- 尽管取得了进展,但早期诊断和治疗仍然具有挑战性.
研究的目的:
- 系统地审查系统性硬化症的新兴向治疗方法.
- 专注于过去三年的I期和II期临床试验.
- 评估这些疗法对疾病进展的影响.
主要方法:
- 系统的文献审查.
- 专注于I期和II期临床试验.
- 分析过去三年内公布的数据.
主要成果:
- 该审查侧重于正在进行的研究和早期阶段的试验.
- 确定新兴的向疗法及其潜在影响.
- 强调需要对新途径进行进一步调查.
结论:
- 早期诊断和干预对于预防不可逆转的SSc损伤至关重要.
- 新的分子和表观遗传研究为个性化治疗策略提供了希望.
- 对向治疗的持续研究对于改善SSc患者的治疗结果至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
153
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
153
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
346
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
346
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152


